Healthcare & Pharma

The global precision medicine market was valued at US$63,333 million in 2021 and is projected to grow at a CAGR of 10.8% during the forecast period 2022-2032.

The global biologics market was valued at US$382.85 billion in 2022 and is projected to grow at a CAGR of 8.82% during the forecast period 2022-2032.

Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032.

The global nanotechnology in drug delivery market was valued at US$53.0 billion in 2021 and is projected to grow at a CAGR of 18.7% during the forecast period 2022-2032.

The global respiratory drug delivery technologies market was valued at US$59.51 billion in 2022 and is projected to grow at a CAGR of 7.31% during the forecast period 2022-2032.

The global artificial intelligence (AI) in drug discovery market was valued at US$791 million in 2021 and is projected to grow at a CAGR of 30.7% during the forecast period 2022-2032.

Global plasma protein therapeutics market is projected to reach a market value of US$59.58 billion in 2032.

The global precision cancer diagnostic test market was valued at US$14,087 million in 2021 and is projected to grow at a CAGR of 15% during the forecast period 2022-2032.

The global vaccine contract manufacturing market was valued at US$9,241.9 million in 2021 and is projected to grow at a CAGR of 7.55% during the forecast period 2022-2032.

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

Rising epidemic potential, a growing emphasis on therapeutic vaccines, and new markets are projected to provide considerable growth prospects for vaccine providers.

The global dual chamber prefilled syringes market driven by the increasing number of lyophilized drugs, the rate of chronic disease incidence is increasing, there is a high demand for low-cost, non-reactive glass dual chamber prefilled syringes, the expansion of the dual chamber prefilled syringes market is aided by advancements in the biopharmaceutical industry.

The increased frequency of zoonotic illnesses, activities by different government agencies and animal groups to protect animal health, and the rising demand for animal-derived food items are driving the expansion of this market.

The 3D cell culture market is experiencing impressive growth globally because of the tremendous increase in demand for biopharmaceutical products. Since its introduction as an integral part of the life science industry, the cell culture market has experienced huge growth in terms of scope as well as adoption by end users.

Increased illness incidence, frequent pandemic outbreaks like as corona and Ebola, and increased expenditures in healthcare facilities such as hospitals and clinics are all boosting demand for hospital beds, resulting in market expansion.

Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.

Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.